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Background: The use of magnetic resonance (MR) imaging as a part of preparation for radiotherapy is increasing.
For delineation of the prostate several publications have shown decreased delineation variability using MR
compared to computed tomography (CT). The purpose of the present work was to investigate the intra- and inter-
physician delineation variability for prostate and seminal vesicles, and to investigate the influence of different MR
sequence settings used clinically at the five centers participating in the study.
Methods: MR series from five centers, each providing five patients, were used. Two physicians from each center
delineated the prostate and the seminal vesicles on each of the 25 image sets. The variability between the
delineations was analyzed with respect to overall, intra- and inter-physician variability, and dependence between
variability and origin of the MR images, i.e. the MR sequence used to acquire the data.
Results: The intra-physician variability in different directions was between 1.3 - 1.9 mm and 3 – 4 mm for the
prostate and seminal vesicles respectively (1 std). The inter-physician variability for different directions were
between 0.7 – 1.7 mm and approximately equal for the prostate and seminal vesicles. Large differences in variability
were observed for individual patients, and also for individual imaging sequences used at the different centers.
There was however no indication of decreased variability with higher field strength.
Conclusion: The overall delineation variability is larger for the seminal vesicles compared to the prostate, due to a
larger intra-physician variability. The imaging sequence appears to have a large influence on the variability, even for
different variants of the T2-weighted spin-echo based sequences, which were used by all centers in the study.
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Successful radiotherapy depends on high geometric and
dosimetric accuracy and precision. The introduction of
treatment planning and dose calculation in 3D, more
than two decades ago, has provided the clinicians with
very good control over the dosimetric aspects of the
treatment with typical relative errors in the order of a* Correspondence: tufve.nyholm@radfys.umu.se
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reproduction in any medium, provided the orfew percent. The more recent introduction of intensity
modulated radiotherapy (IMRT) [1] has made it possible
to shape the dose distribution to closely match the target
volume and the use of image guided radiotherapy
(IGRT) [2] enables reproducible patient positioning at
every treatment fraction. At present, we have come close
to a point where we can “hit the target” with the right
dose every time with minimal dose deposition outside
the intended volume. Hence, treatment precision has
dramatically improved. However, there are still problems
to be solved, as described by Njeh [3]; the uncertainty inl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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more a hazard than a benefit, if the geometric uncer-
tainty in delineation is large.
The use of magnetic resonance (MR) imaging alone,
or together with computed tomography (CT), improves
the target delineation accuracy for many diagnoses [4,5]
and MR imaging is today in routine clinical use at many
centers as a part of the preparation for radiotherapy.
The dedicated MR examination for radiotherapy treat-
ment planning involves issues not present in the diag-
nostic setting. The patient should ideally be imaged in
the same position as during treatment, including fixa-
tions [6] which influence both the coil setup and image
quality [7,8]. The geometric accuracy of the images is
crucial which increase demands on the choice of se-
quences and bandwidth [9] and the sequences and image
planes should be optimized for determination of the pre-
cise geometrical extent of an already known pathology.
There are two alternative ways of incorporating the
MR into the radiotherapy workflow; either the MR im-
ages are seen as a complement to the CT for target def-
inition or the MR replaces the CT throughout the entire
treatment process. The CT/MR workflow is already
established in many centers, but suffers from drawbacks
in terms of increased workload and potential introduc-
tion of geometric errors resulting from the image regis-
tration procedure [10,11]. Fully MR based workflows
have been described in the literature [12-15] and are
considered feasible.
For prostate cancer patients, the use of MR alone or in
combination with CT has been shown to reduce inter-
observer variability in target definition and reduce the
treatment volume [16-19]. The treatment of prostate
cancer has been considered one of the most straightfor-
ward diagnoses for an MR only workflow, as the dose
calculation accuracy in the pelvic region is adequate with
bulk density assignments [20,21] and the commonly
used gold markers are visible with reliable geometric ac-
curacy [22]. In addition to the technical challenges with
the MR based workflow, one must also consider that the
physicians need to adapt to a target definition process
without CT information, and that the MR sequences
need to be optimized for target definition purposes.
The aim of the present multi-center study is to evalu-
ate the intra- and inter-physician variability of prostate
and seminal vesicle volume delineations based on MR
sequences from five different radiotherapy centers in the
clinical setting. All centers participating in the study
were at the time investigating the use of an MR based
workflow for the treatment of prostate cancer. As part
of this process it was considered important to perform
an inter-clinic comparison of both the standard clinical
MR images and the interpretation of the images by the
physicians. The observed variations can be assumed toreflect the clinical reality as the images were acquired
with the standard clinical protocol and the physicians
were instructed to perform the delineation as for an or-
dinary clinical case.
Methods and materials
Five centers were involved in the study; Umeå Uni-
versity Hospital (Umeå, Sweden), Karolinska Hospital
(Stockholm, Sweden), Herlev Hospital (Copenhagen,
Denmark), Newcastle Upon Tyne Hospitals NHS Trust
(Newcastle, United Kingdom) and Beatson West of
Scotland Cancer Centre (Glasgow, United Kingdom). All
centers were, at the time of the study, routinely using
MRI data in their clinical practice for target definition
for prostate cancer patients, except Karolinska who was
in the startup process. Both participating physicians
from Karolinska did however have extensive previous ex-
perience (>5 years) of prostate delineations on MR im-
ages from other hospitals. The different scanners and
sequences used in the study are listed in Table 1. All
centers had chosen to use spin-echo based T2 weighted
images as primary bases for target delineation.
Imaging and preparation of data
Five consecutive patients scheduled for radiotherapy of
the prostate were selected from each site. All patients
had MR examinations as part of their standard prepar-
ation for radiotherapy. The axial images which were typ-
ically used for target delineation were anonymized and
sent to the study coordinator. The 5 image series from
each of the 5 sites were tagged as CT studies in the
DICOM files to enable delineations to be performed dir-
ectly on the MR data in all oncology delineation soft-
ware applications. The set of 25 image series were then
sent to each site and imported into the clinically used
treatment planning systems or dedicated delineation
software.
Delineations
Two physicians from each site independently delineated
the prostate volume and the seminal vesicles. The in-
struction was: “Both prostate and vesicles should be de-
lineated as if a clinical case with high risk for vesicle
involvement”. The prostate and the vesicle delineations
were stored as separate structure sets. After finalizing
the delineations, the structure sets were returned to the
study coordinator as DICOM RTstruct files for analysis.
Analysis
The total dataset consisted of 25 patients, with delinea-
tions from 10 physicians for each patient. All structures
for an individual patient were defined in the same co-
ordinate system and could be directly compared. The
prostate and vesicle volumes were analyzed separately.
Table 1 The sequence used at center C were a 3D sequence (Siemens, SPACE), while the other clinics used 2D sequences
Center Delienation software Scanner Field strength Echo time (ms) Rep. time (ms) Slice thickness (mm) Pixel size (mm2)
A Eclipse Philips Panorama 1.0 T 110 4471 2 0.91 × 0.91
B Eclipse Siemens Verio 3 T 92 3440 3.6 0.52 × 0.52
C ProSoma[MedCom] Siemens Espree 1.5 T 125 3000 1.7 0.78 × 0.78
D Oncentra Siemens Espree 1.5 T 115 10200 3.3 1.17 × 1.17
E Eclipse GE Signa HDxt 1.5 T 90 2520 2.5 0.82 × 0.82
Nyholm et al. Radiation Oncology 2013, 8:126 Page 3 of 12
http://www.ro-journal.com/content/8/1/126For the prostate, the first step was to calculate the
joint center of mass for all delineations for each patient.
The distance from the center was calculated for each de-
lineation in the directions right, left, anterior, posterior,
superior, inferior, right-posterior and left-posterior. To
reduce the influence of small scale variations in the
structure sets and create a representative measure for
the distance, the average over a solid angle Ω =0.49 sr
was used (Figure 1). This procedure provides a single
numerical measure for the distance in the different di-
rections for each patient and delineation.
The joint center of mass for each patient was also used
as a starting point for the analysis of the vesicle delinea-
tions. The shape of the vesicles does not, however, allow
the same analysis approach due to the sometimes con-
cave surface. Instead, the maximum distance in the right,
left, anterior, posterior, superior and inferior directions
from the center of mass were calculated for each
delineation.
Nomenclature
A specific physician is denoted q and a specific patient
p. The complete set of physicians is denoted Q and a
set of patients is denoted P. The center from which aFigure 1 The radial distances from the center of mass to each delinea
directions for an individual delineation was calculated as the average distan
posterior (p), right-posterior (rp), right (r), anterior (a), superior (s), inferior (i)
the relation between the 3D and 2D representation. The example in the figspecific images originates is called imaging center (IC),
and the center where a specific delineation is performed
is called delineation center (DC).
xvarp;q is the observed variable var, which can be either
the volume or the distance in a specific direction. The
current work includes 25 patients (NP = 25) and 10 phy-
sicians ( NQ = 10). The average measure of each delinea-






To remove the systematic variations connected to spe-
cific patients we formed the variable
yvarp;q ¼ xvarp;q  xvarp; ð2Þ
i.e. the difference between an individual physician (q)
delineation on a specific patient (p) and the average
delineation over all physicians, for the delineation char-
acteristic var.
To refer to a specific subgroup of patients imaged at a
specific IC, we use the notation pIC . To refer to the
subgroup of physicians belonging to a specific DC wetion is a function of the angles θ and ∅. The distance in different
ce over a small solid angle in each direction, (left (l), left-posterior (lp),
). The area A, corresponding to the right-posterior direction, illustrates
ure is based on one delineation of one prostate.
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notation A[variable]parameter for the average, and S[vari-
able]parameter for the standard deviation, where the par-




to the average measure of the delineation property var
for all patients coming from imaging center IC.
Statistical analysis
The normality of the data was checked through visual
inspection of Q-Q plots. Most reported significant differ-
ences use a Bonferroni corrected 0.01 confidence level.
The reason for the use of the strict significance levels
was that the main purpose of the tests was to highlight
the most pronounced effects in the dataset, where most
factors can be expected to have influence. Two sided F-
tests were used to compare distributions and t-tests to
compare averages, unless otherwise indicated.
Intra and inter-observer variation
It was assumed that the variable yvarp;q is dependent on
physician (q) and patient (p), i.e.
yvarp;q ¼ wvarq þ zvarp;q ð3Þ
where wq is a factor that is only dependent on the phys-
ician, with expectation value E wvarq
h i
q∈Q
≡ 0 and standard
deviation σvarw . z
var
p;q is a factor dependent on both patient




≡ 0, and standard deviation σvarz . Equation 3
is an ordinary one-way random effect Anova model [23],
where wvarq is the effect of the physician, hence σ
var
w is
interpreted as the inter-physician variation, and zvarp;q
accounts for the residual variation, hence σvarz is inter-
preted as the intra-physician variation (Figure 2).Figure 2 Illustration of the separation of the overall variability into in





be calculated using the equations
svarz














 2 þ NP svarw 2 ¼ NPNQ−1∑NQq¼1 yvar;q
 2
ð5Þ
Confidence intervals for the true variabilities were
found using simulation. The simulation was performed
in a custom written Matlab™ Monte Carlo script. The
script searched the σvarz and σ
var
w space to identify the
area where the probability to get the observed svarz and
svarw or more extreme values was below 5%.
Results
Normality
The differences between delineations from individual
physicians and the average, i.e. yvarp;q , were approximately
normally distributed for all scored variables. There was
however a tendency that the largest deviations were lar-
ger than predicted with a Gaussian model, especially
pronounced for the posterior, right-posterior and left-
posterior directions for the prostate and for the volume
and anterior direction for the vesicles.
Delineation summary
As seen in Table 2 and Figure 3 there are apparent dif-
ferences between the patient samples from the centers.




cantly both for the prostate and vesicles for patients with
imaging center D compared to the others. The mean
relative standard deviation, i.e. A½S ½xvolumep;q qQxvarp; pIC , waster- and intra-physician components. The red dots represent
icate the average observation for the physician.
Table 2 Average delineated prostate and vesicle volumes for patients from the different centers, and the mean
relative standard deviations between the physicians
Prostate Vesicles
Imaging center (IC) Average volume (cm3) Mean relative standard deviation Average volume (cm3) Mean relative standard deviation
A 44 18% 12 22%
B 43 18% 14 33%
C 43 18% 9 33%
D 63(1) 17% 24(1) 44%
E 37 17% 9 37%
(1) – Statistically different from the rest (p < 0.01 bonferroni corrected) 2-sided t-test.
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(Table 2).Variability for different patients
The variability among the physicians differed for differ-
ent patients, as can be seen in Tables 3 and 4 giving the
median, max and min of the standard deviation for indi-






For the prostate, the highest frequency of large devia-
tions (yvarp;q > 4 mmÞ was found in the inferior and anter-
ior directions (8%) each, followed by the superior
direction (6%). The lowest frequency was found in the
right, left and posterior directions (below 3%) while the
frequency was around 5% in posterior-left and posterior-
right directions.
For the vesicles the variability was larger as can be
seen by comparing Tables 3 and 4. The highest fre-
quency of large deviations yvarp;q > 8 mm
 
was found in
the right and left directions (6%), while the frequency
was around 2% in the other directions.Figure 3 The standard deviation, S xvolumep;q
h i
q
; for the volume of the d
of the average volume, xvolumep;q
h i
q
. Each dot represents a patient. The imPhysician variability
The influence of the delineating physician was large and
significant for all investigated variables (p < 0.01,
Kruskal-Wallis test, SPSS). Tables 5 and 6 gives the
intra- and inter-physician variability (1 std) for the dif-
ferent delineation variables, for the prostate and the
seminal vesicles, together with the 95% confidence inter-
val for the true variability.
Variability for different Sequences
All centers participating in the study used T2 weighted
images for target delineation. There were, however, notice-
able differences in the image contrast, as can be appreci-
ated in Figure 4. Tables 7 and 8 gives the variability scored




with the variability for physicians delineating on images








The variability was in general smaller for home center
delineations compared to foreign center delineations.elineations for all 25 patients (prostate and vesicles), as function
aging center is indicated by the dot shape.
Table 3 The median, maximum and minimum observed variability for prostate delineation for an individual patient (1 std)
Anterior Posterior RightPost Right LeftPost Left Superior Inferior Volume
(mm) (mm) (mm) (mm) (mm) (mm) (mm) (mm) (cm3)
Median 1.9 0.8 1.5 1.4 1.7 1.4 1.8 2.5 7.4
Max 4.4 4.6 4.0 3.3 4.0 2.8 4.0 4.0 13.6
Min 0.9 0.4 0.9 0.9 0.7 0.6 1.1 1.0 2.8
Nyholm et al. Radiation Oncology 2013, 8:126 Page 6 of 12
http://www.ro-journal.com/content/8/1/126This was the pattern for all scored variables for the pros-
tate, and was significant for posterior and right/posterior
directions (2-sided F-test p < 0.01 Bonferroni corrected).
For the vesicles the pattern was similar. The variability
was significantly lower for the right and left directions
with images from the physicians home center compared
to foreign center (2-sided F-test p < 0.01 Bonferroni
corrected).
Discussion
Delineation errors have a direct effect on the quality of
the treatment. An excessive target volume entails un-
necessary risk of complications, while an undersized tar-
get reduces the chance of cure. The relationship
between the target definition variability and the extent
of the optimal margin to compensate for geometrical
uncertainties is not completely clear. From a local con-
trol perspective the target definition variability should be
considered a systematic uncertainty affecting the entire
treatment, and should therefore be reflected in the
employed margins. However, the uncertainty in the de-
lineation is heavily dependent on both physician
(Tables 5 and 6) and patient (Tables 3 and 4), which
makes it inadequate to employ generalized margins to
account for the variability. The opinion of the authors of
the present work is that the responsibility to account for
the delineation uncertainty should be placed on the phy-
sicians. The target volume should be delineated to cover
the volume that the physician wants to treat; actively in-
cluding volumes that are of benefit for the patient taking
both local control probability and risk for side effects
into account, and actively excluding volumes that for ex-
ample are close to sensitive healthy tissues and the prob-
ability for tumorous growth is considered small. When
only one physician delineates the target, the delineation
from that physician is the best available estimate for the




Median 3.2 2.0 2.9
Max 7.2 7.5 8.5
Min 1.5 0.8 1.3used without any additional generic margin accounting
for the variability. Hence, the primary effect of improved
imaging leading to decreased variability will not be a
general possibility to reduce the standard margins, but
will rather be reflected in a more uniform and generally
increased treatment quality. Improved consistency will,
as a secondary effect, improve the statistical power when
evaluating and optimizing treatment protocols in clinical
trials.
A way to decrease variability is through training and
experience [24]. In Tables 7 and 8 it can be seen that
physicians’ delineation on images from their home cen-
ter generally were closer to the average compared to
when delineating on images from foreign centers. In
some directions the difference was up to 40% (for ex-
ample posterior direction for the prostate). This effect
may be attributed to customization and experience of
the local MR sequence. Another way to potentially de-
crease the variability is to optimize the MR sequence. It
is however ambitious to optimize with respect to the
delineation variability. Data from the present work
does not indicate reduced variability when using a 3 T
scanner (center B), but the observations for the single
3 T scanner and only one sequence may not to be
representative.
Intra-observer variation has often been reported based
on repeated delineation on a single image set by one or
several physicians. The approach used in this work is
based on the analysis of variance theory [23] and has
been described for the present application by Remeijer
et al. [25]. It does not rely on multiple delineations by
the same physician on individual images. To be able to
make the separation we assumed that the intra-physician
variability was equal for all physicians. In practice this
was not the case. For all scored variables there was at
least one physician with significantly different variability
(F-test p < 0.01 Bonferroni corrected). In addition,bility for seminal vesicle delineation for an individual
Left Superior Inferior Volume
(mm) (mm) (mm) (cm3)
3.7 2.8 3.3 3.0
7.6 5.8 8.0 16.8
0.7 1.3 1.5 1.5
Table 5 Separation between intra- and inter-physician variability (1 std) for the prostate in different directions and for
the volume
Anterior Posterior RightPost Right LeftPost Left Superior Inferior Volume
(mm) (mm) (mm) (mm) (mm) (mm) (mm) (mm) (cm3)
Intra 1.7 1.4 1.6 1.4 1.6 1.3 1.5 2.0 5.5
(1.9-1.6) (1.5-1.3) (1.7-1.4) (1.6-1.3) (1.8-1.5) (1.5-1.2) (1.6-1.3) (2.2-1.8) (6.1-5.0)
Inter 1.5 0.7 1.3 1.0 1.4 0.9 1.6 1.7 6.03
(2.8-1.0) (1.3-0.4) (2.4-0.9) (1.75-0.6) (2.5-0.9) (1.7-0.6) (2.9-1.1) (3.1-1.1) (11.0-4.0)
The numbers within brackets below each estimate indicates the 95% confidence interval.
Nyholm et al. Radiation Oncology 2013, 8:126 Page 7 of 12
http://www.ro-journal.com/content/8/1/126Tables 7 and 8 shows that the variability depends on the
origin of the images (home vs. foreign center) as men-
tioned above. This phenomenon was not accounted for
in the separation model. The numbers in Tables 5 and 6
are representative values describing the observations in
the present study, but should be interpreted with these
reservations in mind.
A concern when setting up the study was that the ob-
served overall variability would primarily reflect the use
of different clinical routines and traditions at the differ-
ent centers. The separation of the variability into inter-
and intra-physician components did however reveal that
the intra-physician variability was dominating both for
the prostate and especially for the seminal vesicles.
There were significant differences between different de-
lineation centers, the physicians from center A and D
did on average delineate 20-30% larger prostate volumes
compared to the physicians from centers B, C and E, but
the dominating source for variability in individual direc-
tions was still the intra-physician variability. The in-
crease of overall variability for the seminal vesicles
delineation compared to the prostate delineation
could be fully attributed to the larger intra-physician
variability.
The inter-physician variability observed in the present
study, summarized in Table 5, is approximately in line
with the observations described in the literature. Rasch
et al. found an inter-physician variability in the inferior
region (apex) and superior region of around 1 mm
(1.7 mm and 1.6 mm in present study) using axial
MR images for 18 patients and with 3 observers [16].
The intra-observer variability was around 3 mm in bothTable 6 Separation between intra- and inter-physician variab
Anterior Posterior Right
(mm) (mm) (mm)
Intra 3.9 2.9 3.6
(4.3-3.6) (3.2-2.6) (4.0-3.3)
Inter 1.6 1.0 0.8
(3.1-0.9) (2.1-0.6) (1.8-0.2)
The numbers in hard brackets for the right directions are calculated with one extre
indicates the 95% confidence interval.regions (2.0 mm and 1.5 mm in present study). It should
be noted that Rasch et al. used a similar separation of
variance as utilized in the present work, but the low
number of physicians make the estimates for the inter-
physician variability uncertain. Smith et al. reported
inter-observer volume variability of 4.6 cm3 (6.1 cm3 in
present study), and intra-physician volume variability of
2.7 cm3 based on repeated observations on same patient
(5.1 cm3 in present study), in a study with 10 patients
and 7 observers [26]. The large difference between the
intra-physician variability in the present study compared
to the study by Smith et al. could be due to the use of
repeated delineations on the same image to estimate the
intra-physician variability compared to separation of
variances.
The results from the present study are also approxi-
mately in line with variability reported in the literature
for CT based delineations. Fiorino et al. [27] has
reported a study using 6 patients and 5 observers and
found a short term intra-physician variation of 0.8, 1.1,
1.5 mm for the posterior, anterior and right/left direc-
tions to be compared with intra-physician variability 1.4,
1.7 resp. 1.9 mm found in the present study. The inter-
observer standard deviation was estimated by Fiorino
et al. to 1.4, 1.5 and 2.0 mm in the anterior, posterior
and left-right directions, which should be compared with
the approximately equivalent numbers found in Table 5,
i.e. 0.7, 1.5 and 1.3 mm. For the vesicles Fiorino et al.
reported inter-observer variability of 1.5, 2.8 and 2.3 mm
in the posterior, anterior and lateral directions (1.0, 1.6,
1.5 mm in present work), and intra-observer variability
of 1.2, 1.2, 1.5 (2.9, 3.9, 5.2 mm present work). Theility (1 std) for the seminal vesicles
Left Superior Inferior Volume
(mm) (mm) (mm) (cm3)
3.8 2.9 3.5 5.7
(4.2-3.5) (3.2-2.7) (3.8-3.1) (5.2-6.3)
1.3 1.6 1.7 2.8
(2.7-0.7) (3.0-1.0) (3.2-1.0) (5.4-1.7)
me outlier removed (>4 cm). The numbers within brackets below each estimate
Figure 4 Examples of the image quality of the images from the different centers (prostate and seminal vesicles).
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stantial decrease in the variability when using MR com-
pared to CT. This indicates that the benefit of MR is
more in terms of accuracy than precision. To enable
comparison with the results form Fiorino et al. in the
right-left direction, the variability in the right and leftdirections from the present work was added together as-
suming these are independent variables.
The present work is based on a total of 250 delinea-
tions performed by 10 physicians on 25 patients. This
is a large study and provides relatively tight 95%
confidence intervals especially for the intra-physician
Table 7 Mean standard deviation for imaging sites
Imaging center Anterior Posterior RightPost Right LeftPost Left Superior Inferior Volume
(IC) (mm) (mm) (mm) (mm) (mm) (mm) (mm) (mm) (Cm3)
A 1.6 0.9 1.8 1.8 1.7 1.5 1.9 2.3 6.6
B 3.3 0.9 1.6 1.5 1.5 1.2 2.7 2.5 7.7
C 1.8 0.9 1.3 1.5 1.6 1.2 2.0 2.3 6.7
D 2.4 2.5 2.7 1.4 2.7 1.6 2.0 2.9 10.8
E 1.4 1.4 2.2 2.0 2.4 2.0 1.7 2.3 6.4
Home 1.7 0.9 1.4 1.3 1.6 1.4 1.8 2.5 6.1
Foreign 2.3 1.6 2.1 1.7 2.1 1.6 2.1 2.5 8.1
Bold figures mean statistically significant larger and italic significantly smaller variation compared to other imaging centers (bonferroni correction p < 0.01) F-test.
The two last rows compares the average standard deviation for delineations performed on images from physicians home center compared to images from a
foreign center.
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confidence intervals for the true standard deviation σ is
to make use of the relation between the ratio the of esti-





Where DF is the degrees of freedom. For the intra-
physician variation in the present study DF = (NQ − 1)
(NP − 1). The confidence interval for σvarw can also be es-
timated using equation 6 (DF =NQ − 1). but especially in
cases when the σvarw ≪σ
var
z this estimation will lead to an
underestimation of the confidence interval. For the pros-
tate, where the intra-physician and inter-physician vari-
ability was of the same magnitude, the use of equation 6
gives approximately the same results as simulation. For
example in the inferior direction for the prostate, where
the simulations and equation 6 gave equivalent results
with 0.1 mm precision. But for the vesicles, where the
intra-physician variability was larger compared to the
inter-physician variability, the use of equation 6 under-
estimates the confidence interval. For example theTable 8 Mean standard deviation for imaging sites (vesicles)
Imaging center Anterior Posterior Right
(IC) (mm) (mm) (mm)
A 3.2 1.2 2.6
B 3.0 3.4 3.1
C 4.0 1.8 2.9
D 6.2 4.0 5.6
E 2.8 3.4 3.6
Home 3.9 2.4 2.9
Foreign 4.0 3.1 5.0
Bold figures mean statistically significant larger and italic significantly smaller variat
The two last rows compares the average standard deviation for delineations perform
foreign center.confidence interval for the inter-physician variability in
the posterior direction was simulated to 2.1-0.6 mm,
while equation 6 gave 1.9-0.7 mm. This can be under-
stood considering the scenario with a very large intra-
observer variation creating random variations between
physicians, and making the inter-observer variation diffi-
cult to quantify. The reporting of confidence intervals is
very important, especially when using small sample sizes
and/or separation of variances into components.
A clinical objective of the present work was to provide
feedback to physicists optimizing the MR sequences at
the different sites and to the physicians doing the delin-
eations. For the physicians the feedback consisted of two
parts. The images sets for the 25 patients were returned
to each physician with their own delineations shown as a
white structure set and the other 9 delineations shown
as black structures. See Figure 5 for example of the de-
lineation variability. The purpose of this feedback was to
give an indication of their performance in relation to the
others. In addition a one day workshop was organized
where a selection of the patient cases were reviewed to-
gether with two radiologists specialized in MR examina-
tions of the prostate and seminal vesicles. The outcome
of this workshop was that the average delineation of theLeft Superior Inferior Volume
(mm) (mm) (mm) (cm3)
3.0 2.3 2.2 2.7
4.2 3.8 3.6 5.2
2.9 2.9 2.9 3.7
5.3 4.0 5.1 11.3
3.4 2.7 3.9 2.8
2.7 3.2 3.9 5.2
4.1 3.2 3.6 6.2
ion compared to other imaging centers (Bonferroni correction p < 0.01) F-test.
ed on images from physicians home center compared to images from a
Figure 5 Examples of the delineations (prostate and seminal vesicles).
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the opinion of the radiologists, while the delineations of
the vesicles performed by the radiation oncologists
tended to overestimate the extent of the seminal vesicles
for some patients, especially in the anterior and right-
left directions. The radiologists preferred the image
quality provided by center B, followed by the image
quality from center D. It is interesting to notice that the
images from these sites were associated with the largest
delineation variability. Our interpretation is that in-
creased amount of information increases the scope for
interpretation and hence the importance of training and
experience. It also highlights the complexity of the
optimization procedure and the importance of a well de-
fined objective for the optimization. If the objective is to
reduce the delineation variability of the prostate or the
seminal vesicles it could be counter-productive to use
sequences optimized to visualize pathology. Our opinion
is that recommendations on specific sequence settings
are difficult to make because of the different needs and
possibilities at different centers. For example, if high
quality diagnostic images are already available for a pa-
tient there is less need to acquire images optimized for
pathology.
Conclusion
The overall intra- and inter-physician variability for
prostate and seminal vesicle delineations was determined
for clinically used MR sequences optimized for target
volume determination at 5 different radiotherapy centers
in Europe. Large differences in variability were observed
between different patients, but also between different MR
sequences, even though all centers used T2-weighted
spin-echo based sequences. The intra-physician variability
was significantly larger for the seminal vesicles compared
to the prostate, while the inter-physician variability was
approximately the same.
Competing interests
The author(s) declare that they have no competing interests.
Authors’ contributions
TN, BZ and JJ conceived the study. All authors participated in the design of
the study, data generation and data collection. TN and JJ drafted the
manuscript. All authors read and approved the final manuscript.
Author details
1Department for Radiation Sciences, Radiation Physics, Umeå University,
Umeå, Sweden. 2Department for Radiation Sciences, Oncology, Umeå
University, Umeå, Sweden. 3Department of Medical Physics, Karolinska
University Hospital, Solna, Sweden. 4Department of Oncology, Karolinska
University Hospital, Solna, Sweden. 5Department of Oncology, Herlev
University Hospital, Herlev, Denmark. 6Department of Oncology, Hillerød
Hospital, Hillerød, Denmark. 7Department of Clinical Physics and
Bioengineering, Radiotherapy Physics, Beatson West of Scotland Cancer
Centre, Glasgow G12 0YNScotland, UK. 8Department of Clinical Oncology,
Beatson West of Scotland Cancer Centre, Glasgow G12 0YNScotland, UK.
9Northern Centre for Cancer Care, Newcastle-Upon-Tyne Hospitals NHS Trust,
High Heaton, Newcastle upon Tyne, UK.Received: 31 October 2012 Accepted: 28 March 2013
Published: 24 May 2013
References
1. Bortfeld T: IMRT: a review and preview. Phys Med Biol 2006, 51:R363–R379.
2. Chen GTY, Sharp GC, Mori S: A review of image-guided radiotherapy.
Radiol Phys Technol 2009, 2:1–12.
3. Njeh CF: Tumor delineation: The weakest link in the search for accuracy
in radiotherapy. J Med Phys 2008, 33:136–140.
4. Rasch C, Steenbakkers R, van Herk M: Target Definition in Prostate, Head,
and Neck. Semin Radiat Oncol 2005, 15:136–145.
5. Khoo VS, Joon DL: New developments in MRI for target volume
delineation in radiotherapy. Br J Radiol 2006, 79 Spec No:S2–S15.
6. Karlsson M, Karlsson MG, Nyholm T, Amies C, Zackrisson B: Dedicated
magnetic resonance imaging in the radiotherapy clinic. Int J Radiat Oncol
Biol Phys 2009, 74:644–651.
7. Hanvey S, Glegg M, Foster J: Magnetic resonance imaging for
radiotherapy planning of brain cancer patients using immobilization and
surface coils. Phys Med Biol 2009, 54:5381–5394.
8. McJury M, O’Neill A, Lawson M, McGrath C, Grey A, Page W, O’Sullivan JM:
Assessing the image quality of pelvic MR images acquired with a flat
couch for radiotherapy treatment planning. Br J Radiol 2011, 84:750–755.
9. Fransson A, Andreo P, Pötter R: Aspects of MR Image Distortions in
Radiotherapy Treatment Planning. Strahlentherapie 2001, 177:59–73.
10. Nyholm T, Nyberg M, Karlsson MG, Karlsson M: Systematisation of spatial
uncertainties for comparison between a MR and a CT-based
radiotherapy workflow for prostate treatments. Radiat Oncol 2009, 4:54.
11. Ulin K, Urie MM, Cherlow JM: Results of a multi-institutional benchmark
test for cranial CT/MR image registration. Int J Radiat Oncol Biol Phys 2010,
77:1584–1589.
12. Prabhakar R, Julka PK, Ganesh T, Munshi A, Joshi RC, Rath GK: Feasibility of
using MRI alone for 3D radiation treatment planning in brain tumors.
Jpn J Clin Oncol 2007, 37:405–411.
13. Beavis AW, Gibbs P, Dealey RA, Whitton VJ: Radiotherapy treatment
planning of brain tumours using MRI alone. Br J Radiol 1998, 71:544–548.
14. Lee YK, Bollet M, Charles-edwards G, Flower MA, Leach MO, Mcnair H,
Moore E, Rowbottom C, Webb S: Radiotherapy treatment planning of
prostate cancer using magnetic resonance imaging alone. Science 2003,
66:203–216.
15. Buhl SK, Duun-Christensen AK, Kristensen BH, Behrens CF: Clinical
evaluation of 3D/3D MRI-CBCT automatching on brain tumors for online
patient setup verification - A step towards MRI-based treatment
planning. Acta Oncol 2010, 49:1085–1091.
16. Rasch C, Barillot I, Remeijer P, Touw A, van Herk M, Lebesque JV: Definition
of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol
Biol Phys 1999, 43:57–66.
17. Villeirs GM, Van Vaerenbergh K, Vakaet L, Bral S, Claus F, De Neve WJ,
Verstraete KL, De Meerleer GO: Interobserver delineation variation using
CT versus combined CT +MRI in intensity-modulated radiotherapy for
prostate cancer. Strahlenther Onkol 2005, 181:424–430.
18. Debois M, Oyen R, Maes F, Verswijvel G, Gatti G, Bosmans H, Feron M,
Bellon E, Kutcher G, van Poppel H, Vanuytsel L: The contribution of
magnetic resonance imaging to the three-dimensional treatment
planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 1999,
45:857–865.
19. Wachter S, Wachter-Gerstner N, Bock T, Goldner G, Kovacs G, Fransson A,
Pötter R: Interobserver Comparison of CT and MRI-Based Prostate Apex
Definition. Strahlenther Onkol 2002, 178:263–268.
20. Jonsson JH, Karlsson MG, Karlsson M, Nyholm T: Treatment planning using
MRI data: an analysis of the dose calculation accuracy for different
treatment regions. Radiat Oncol 2010, 5:62.
21. Lambert J, Greer PB, Menk F, Patterson J, Parker J, Dahl K, Gupta S, Capp A,
Wratten C, Tang C, Kumar M, Dowling J, Hauville S, Hughes C, Fisher K, Lau
P, Denham JW, Salvado O: MRI-guided prostate radiation therapy
planning: Investigation of dosimetric accuracy of MRI-based dose
planning. Radiother Oncol 2011, 98:330–334.
22. Jonsson JH, Garpebring A, Karlsson MG, Nyholm T: Internal Fiducial
Markers and Susceptibility Effects in MRI-Simulation and Measurement
of Spatial Accuracy. Int J Radiat Oncol Biol Phys 2012, 82(5):1612–1618.
23. Fisher RA: Statistical Methods for Research Workers. Edinburgh: Oliver and
Boyd; 1925.
Nyholm et al. Radiation Oncology 2013, 8:126 Page 12 of 12
http://www.ro-journal.com/content/8/1/12624. Khoo ELH, Schick K, Plank AW, Poulsen M, Wong WWG, Middleton M, Martin
JM: Prostate Contouring Variation: Can It Be Fixed? Int J Radiat Oncol Biol
Phys 2012, 82(5):1923–1929.
25. Remeijer P, Rasch C, Lebesque JV, van Herk M: A general methodology for
three-dimensional analysis of variation in target volume delineation. Med
Phys 1999, 26:931–940.
26. Smith WL, Lewis C, Bauman G, Rodrigues G, D’Souza D, Ash R, Ho D,
Venkatesan V, Downey D, Fenster A: Prostate volume contouring: a 3D
analysis of segmentation using 3DTRUS, CT, and MR. Int J Radiat Oncol
Biol Phys 2007, 67:1238–1247.
27. Fiorino C, Reni M, Bolognesi A, Cattaneo GM, Calandrino R: Intra- and inter-
observer variability in contouring prostate and seminal vesicles:
implications for conformal treatment planning. Radiother Oncol 1998,
47:285–292.
doi:10.1186/1748-717X-8-126
Cite this article as: Nyholm et al.: Variability in prostate and seminal
vesicle delineations defined on magnetic resonance images, a multi-
observer, -center and -sequence study. Radiation Oncology 2013 8:126.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
